Nile, founded in 2020 and based in the United States, is pioneering advancements in epilepsy care by leveraging cutting-edge AI technology. Their slogan, "Replacing Trying with Knowing in Epilepsy Care", encapsulates their mission to curate a personalized, data-driven treatment journey for epilepsy patients, streamlining communication between patients and care providers.
Active in the AI and Health Care industries, Nile received a substantial €25.00M Corporate Round investment on 13 January 2021 from Union Chimique Belge. This investment underscores confident backing from industry leaders, signalling the potential Nile holds in transforming epilepsy care through technology.
Nile is now actively seeking further partnerships in the health tech sector. Their innovative platform promises to replace uncertainty in treatment selection with data-backed decisions, offering a compelling opportunity for stakeholders looking to make impactful investments in healthcare innovation.